Trading / Browse Companies / Tempest Therapeutics Stock

Tempest Therapeutics Stock

tempesttx.comHealthcareFounded: 1900Funding to Date: $75.2MM

Tempest Therapeutics is a clinical-stage biotechnology company advancing small molecule therapeutics that modulate anti-tumor immunity pathways.

Buy or sell Tempest Therapeutics stockLearn more about Tempest Therapeutics IPO
Register for Details

For more details on financing and valuation for Tempest Therapeutics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Tempest Therapeutics.

Register Today

Team

Management Team

Chan Whiting Ph.D
Senior Vice President of Research & Development
Thomas Dubensky Ph.D
Chief Executive Officer, President & Board Member
Peppi Prasit Ph.D
Acting Chief Scientific Officer & Director
Ginna Laport MD
Chief Medical Officer

Board Members

Bradley Bolzon Ph.D
Versant Venture Management
Thomas Woiwode Ph.D
Versant Venture Management
Robert Weisskoff Ph.D
F-Prime Capital Partners
Stella Xu Ph.D
Quan Capital
Peppi Prasit Ph.D
Thomas Dubensky Ph.D
Tempest Therapeutics

Other companies like Tempest Therapeutics in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
NowRx
Sector
Healthcare
Last Round Est. Valuation
$334.19MM
Headspace
Sector
Healthcare
Last Round Est. Valuation
$317.32MM
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
GoForward
Sector
Healthcare
Last Round Est. Valuation
$885.01MM
Biosplice Therapeutics
Sector
Healthcare
 
 

News

Market Screener 11/08/2019
Tempest Therapeutics' Oncology Programs Presented at Society of Immunotherapy for Cancer Annual Meeting

Trending Companies

Frequently Asked Questions